Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Margins of Excision 2Urologic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Lesion 1Prostatic Neoplasms 1Nevus, Pigmented 1Nephrolithiasis 1Multicystic renal dysplasia, bilateral 1Melanoma 1Hematuria 1Carcinoma, Basal Cell 1Adenocarcinoma 1

Interventions

Nivolumab 7cemiplimab 6Specimen Handling 5HhAntag691 5Radiotherapy 4Magnetic Resonance Spectroscopy 4Ipilimumab 4Biopsy 4sonidegib 3pembrolizumab 3CTLA-4 Antigen 3relatlimab 2prednylidene 2deltacortene 2daromun 2Surgical Procedures, Operative 2Standard of Care 2Prednisone 2Observation 2Aminolevulinic Acid 2tocilizumab 1talimogene laherparepvec 1poly ICLC 1flt3 ligand protein 1X-Rays 1Watchful Waiting 1Vitamin D 1Tomography, Optical Coherence 1Therapeutics 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × Microscopy, Confocal × 1 year × Clear all
NCT05935995 2025-11-28

HISTOBLOC

Institut de Cancérologie de Lorraine

Phase NA Active not recruiting
42 enrolled
DermatologicHead & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡